Loading...
Transglutaminase activation in neurodegenerative diseases
Jeitner, Thomas M. Muma, Nancy A. Battaile, Kevin P. Cooper, Arthur J. L.
Jeitner, Thomas M.
Muma, Nancy A.
Battaile, Kevin P.
Cooper, Arthur J. L.
Citations
Altmetric:
Abstract
The following review examines the role of calcium in promoting the in vitro and in vivo activation of transglutaminases in neurodegenerative disorders. Diseases such as Alzheimer's disease, Parkinson's disease and Huntington's disease exhibit increased transglutaminase activity and rises in intracellular calcium concentrations, which may be related. The aberrant activation of transglutaminase by calcium is thought to give rise to a variety of pathological moieties in these diseases, and the inhibition has been shown to have therapeutic benefit in animal and cellular models of neurodegeneration. Given the potential clinical relevance of transglutaminase inhibitors, we have also reviewed the recent development of such compounds.
Description
Date
2010-05-01
Journal Title
Journal ISSN
Volume Title
Publisher
Future Medicine
Collections
Files
Loading...
muma_transglutaminase.pdf
Adobe PDF, 2.66 MB
Research Projects
Organizational Units
Journal Issue
Keywords
Alzheimer's disease, Calcium, Huntington's disease, Neurodegeneration, Parkinson's disease, Transglutaminase
Citation
Jeitner, Thomas M., Nancy A. Muma, Kevin P. Battaile, and Arthur Jl Cooper. "Transglutaminase Activation in Neurodegenerative Diseases." Future Neurology 4.4 (2009): 449-67.